A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...
GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...
Pre-existing medical conditions are easily overlooked, especially when they’re relatively minor, but they could end up ...
A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, ...
Asthma patients can help their own health, and that of others, by taking part in clinical trials. There's no charge for ...
Our expert pharmacist warns against mixing these medications with your morning cup of coffee.
The runny nose, the coughing – while the discomfort is never fun, knowing if you (or your children) have a virus or just ...
Sanofi says lunsekimig hit Phase 2 endpoints in asthma and CRSwNP, showing dual TSLP/IL-13 blockade and solid safety—read ...
Seasonal changes can worsen asthma and allergies due to triggers like pollen, pollution and humidity. A doctor explains how ...
An NHS GP is encouraging hay fever sufferers to incorporate some additional methods into their treatment arsenal this year ...
Sanofi's lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP The AIRCULES phase 2b study achieved its primary and key secondary endpoints in moderate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results